October 16, 2023
Projected Growth in FDA-Approved Artificial Intelligence Products Given Venture Capital Funding
Medical imaging accounts for 85% of digital health’s venture capital funding. As funding grows, it is expected that artificial intelligence (AI) products will increase commensurately. The study’s objective is to project the number of new AI products given the statistical association between historical funding and FDA-approved AI products.
Read the JACR study for full details.